can tirzepatide cause pancreatic cancer Adverse events associated with tirzepatide: a focus on subgroup-specific differences | BMC Pharmacology and Toxicology Ozempic and Cancer Risk: Study

(Former nail biter checking in!) It can be a difficult habit to quit, but a subset of GLP-1 users have reported that since they began taking the medication, theyve lost interest in nibbling their nails

The injection is administered subcutaneously in the abdomen, thigh, or back of the upper arm

GLP-1 and similar hormone-activating medications can significantly reduce appetite, support weight loss and control blood sugar

Tirzepatide is the next-generation GLP-1 drug a dual-action peptide that targets both GLP-1 and GIP receptors and produces meaningfully greater weight loss than semaglutide in head-to-head trials